LNP Encapsulation of mRNA Cargo

LNP Encapsulation of mRNA Cargo

LNP encapsulation is essential for successfully applying mRNA therapeutics, especially in rapidly evolving areas like personalized medicine and response to health challenges. This step refers to the encapsulation of mRNA within lipid nanoparticles (LNPs) after a mixing and self-assembly process. This method is crucial for delivering mRNA effectively to target cells in the body because mRNA is inherently unstable.

Depending on your stage of development and scale up, mixing the lipid components and mRNA can be done with liquid handlers or microfluidic devices. A Beckman Coulter Life Sciences Optima AUC can help assess payload copy numbers as well as free and bound cargo that may be present in formulations.

Mixing and encapsulation processes can negatively impact mRNA integrity. To understand how your process impacts mRNA integrity and encapsulation efficiency, consider the 8-capillary SCIEX BioPhase 8800 system. Leverage the PA 800 Plus system to obtain detailed information on poly(A) tail distribution with single nucleotide resolution and mRNA integrity and purity as part of your release testing criteria.

Data management is essential for tracking the encapsulation efficiency, stability and release profiles of mRNA-loaded LNPs. This information is critical for ensuring the therapeutic efficacy and safety of the final product. Genedata and IDBS provide scalable, enterprise-level cloud software products from R&D through manufacturing for assured confidence in both GxP and non-GxP environments.

Genedata Biopharma Platform offers a comprehensive solution for LNP encapsulation of mRNAs and other cargo. It streamlines MS-based characterization and monitoring of all mRNA and oligonucleotide variations. Utilizing dedicated APIs that connect directly to instruments, it automates the analysis of plate-based and imaging assays, delivering insights into mRNA encapsulation efficiency, safety, toxicity, cell trafficking, and protein expression. Out-of-the-box, the platform establishes a structured data foundation encompassing every step of the LNP life cycle and facilitates automated quality control through two-way communication with liquid handlers.

IDBS Polar is a fully configurable drug development workflow and data management software platform. IDBS Polar enables scientists to capture experiment, inventory, analysis, equipment and operational data at the point of execution in a sophisticated data backbone that enables actionable insights and drives data-driven decision-making. Capabilities within IDBS Polar software allow scientists to design, execute and analyze experiments within a single platform to understand process performance, product quality, genealogical traceability and encapsulation efficiency.

If your laboratory lacks the necessary safeguards and personnel—requirements that often require significant investments—or if you prefer not to manage multiple partnerships, consider outsourcing your LNP work to a reliable partner like Aldevron. Aldevron can support you throughout the entire mRNA-LNP therapeutic process, from creating plasmids and in vitro transcription of mRNA to analytical development and validation to process development and manufacturing.